Paying for medicines licences, clinical trials and clinical investigations is changing from 1 April the Medicines and Healthcare products Regulatory Agency (MHRA) announced.
Instead of paying in advance, a new ‘Pay on Invoice’ process will streamline the way we manage a range of applications.
From 1 April those making applications will no longer need to attach proof of payment making the end-to-end process simpler, easier and quicker.
The benefits of the new process include removing the need to work out complex fees and reducing the chance of applications being rejected for incorrect payment details.
Additionally the simplified payment process should result in fewer delays and make it easier for companies to reconcile financial records and accounts.
Overall the process is aimed at saving companies time and money.